{"id":7634,"date":"2025-09-22T08:00:00","date_gmt":"2025-09-22T06:00:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/"},"modified":"2025-11-06T08:12:14","modified_gmt":"2025-11-06T07:12:14","slug":"nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/","title":{"rendered":"Nanexa erh\u00e5ller japanskt patentgodk\u00e4nnande f\u00f6r specifik PharmaShell-struktur"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>Godk\u00e4nnandet st\u00e4rker Nanexas patentportf\u00f6lj, med ytterligare patentans\u00f6kningar inl\u00e4mnade i andra strategiskt viktiga l\u00e4nder<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Nanexa meddelar att en viktig patentans\u00f6kan har beviljats i Japan och f\u00e5tt patentnumret JP7733651B2. Den patenterade uppfinningen g\u00e4ller en specifik struktur i skalet som anv\u00e4nds i PharmaShell-plattformen.<\/p>\n<p>Patentans\u00f6kningar f\u00f6r samma patentfamilj har \u00e4ven l\u00e4mnats in i andra kommersiellt och strategiskt viktiga l\u00e4nder, inklusive USA och Europa. Patentet f\u00f6rv\u00e4ntas g\u00e4lla fram till \u00e5tminstone december 2039.<\/p>\n<p>Dessutom har Nanexa under de senaste m\u00e5naderna l\u00e4mnat in tre nya patentans\u00f6kningar som t\u00e4cker innovativa f\u00f6rb\u00e4ttringar av PharmaShell-teknologin, vilka f\u00f6retaget anser vara b\u00e5de viktiga och m\u00f6jligg\u00f6rande. Dessa ans\u00f6kningar f\u00f6rv\u00e4ntas avsev\u00e4rt st\u00e4rka patentportf\u00f6ljen och, om de beviljas, ge ytterligare lager av skydd f\u00f6r teknologin fram till 2046.<\/p>\n<p>Anders Johansson, medgrundare och Head of Intellectual Property p\u00e5 Nanexa, kommenterar:<br \/>&#34;F\u00f6rdelen med att vara pionj\u00e4rer inom ett specifikt omr\u00e5de \u00e4r att man \u00e4r b\u00e4st positionerad att l\u00f6sa f\u00e4ltets tekniska utmaningar genom innovation. Vi har alltid varit, och forts\u00e4tter att vara, noggranna med att skydda alla nya uppfinningar strategiskt och helt\u00e4ckande. Genom \u00e5ren har detta gjort det m\u00f6jligt f\u00f6r oss att bygga en bred och stark patentportf\u00f6lj.&#34;<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-2376405b3437\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information kontakta:<\/strong><\/p>\n<hr\/>\n<p>David Westberg \u2013 vd, Nanexa AB (publ)\u00a0<br \/>Telefon: 0709-42 83 03<br \/>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\" rel=\"noopener\" target=\"_blank\">david.westberg@nanexa.se<\/a><br \/><a href=\"http:\/\/www.nanexa.com\" rel=\"noopener\" target=\"_blank\">www.nanexa.com<\/a><\/p>\n<p>Bolagets Certified Adviser \u00e4r DNB Carnegie Investment Bank AB (publ).<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-c9ba281e2dde\">\n<p><strong class=\"mfn-heading-1\">Om Nanexa AB (publ)<\/strong><\/p>\n<hr\/>\n<p>Nanexa introducerar kontroll, precision och m\u00e5ngsidighet till l\u00e4kemedelsformuleringar med hj\u00e4lp av ALD-teknik (Atomic Layer Deposition). F\u00f6retagets patenterade PharmaShell\u00ae-plattform \u00e4r ett unikt drug delivery-system som m\u00f6jligg\u00f6r h\u00f6g drug load vilket ger l\u00e5g injektionsvolym och skapar en ny generation formuleringar, s\u00e5 kallade \u201dsuper generics\u201d som ger st\u00f6rre bekv\u00e4mlighet och minskar kostnaderna vid behandling av allehanda sjukdomstillst\u00e5nd som metabola sjukdomar, t.ex. typ 2-diabetes och obesitas, hematologi\/onkologi, hj\u00e4rt-k\u00e4rlsjukdomar, psykiatri och m\u00e5nga andra.<br \/>Nanexa utvecklar egna l\u00e4kemedelsprodukter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland Novo Nordisk och AstraZeneca.<\/p>\n<p>Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/4338091b-d2ab-4905-84c7-66869c6327a0\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur.pdf\" rel=\"noopener\" target=\"_blank\">Nanexa erh\u00e5ller japanskt patentgodk\u00e4nnande f\u00f6r specifik PharmaShell-struktur<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Godk\u00e4nnandet st\u00e4rker Nanexas patentportf\u00f6lj, med ytterligare patentans\u00f6kningar inl\u00e4mnade i andra strategiskt viktiga l\u00e4nder<\/p>\n","protected":false},"template":"","class_list":["post-7634","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-ext-nq_sv","mfn-news-tag-mfn-ext-nq-company-announcement_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa erh\u00e5ller japanskt patentgodk\u00e4nnande f\u00f6r specifik PharmaShell-struktur - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa erh\u00e5ller japanskt patentgodk\u00e4nnande f\u00f6r specifik PharmaShell-struktur - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Godk\u00e4nnandet st\u00e4rker Nanexas patentportf\u00f6lj, med ytterligare patentans\u00f6kningar inl\u00e4mnade i andra strategiskt viktiga l\u00e4nder\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-06T07:12:14+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\\\/\",\"name\":\"Nanexa erh\u00e5ller japanskt patentgodk\u00e4nnande f\u00f6r specifik PharmaShell-struktur - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2025-09-22T06:00:00+00:00\",\"dateModified\":\"2025-11-06T07:12:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa erh\u00e5ller japanskt patentgodk\u00e4nnande f\u00f6r specifik PharmaShell-struktur\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa erh\u00e5ller japanskt patentgodk\u00e4nnande f\u00f6r specifik PharmaShell-struktur - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa erh\u00e5ller japanskt patentgodk\u00e4nnande f\u00f6r specifik PharmaShell-struktur - Nanexa AB","og_description":"Godk\u00e4nnandet st\u00e4rker Nanexas patentportf\u00f6lj, med ytterligare patentans\u00f6kningar inl\u00e4mnade i andra strategiskt viktiga l\u00e4nder","og_url":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/","og_site_name":"Nanexa AB","article_modified_time":"2025-11-06T07:12:14+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/","url":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/","name":"Nanexa erh\u00e5ller japanskt patentgodk\u00e4nnande f\u00f6r specifik PharmaShell-struktur - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2025-09-22T06:00:00+00:00","dateModified":"2025-11-06T07:12:14+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-erhaller-japanskt-patentgodkannande-for-specifik-pharmashell-struktur\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa erh\u00e5ller japanskt patentgodk\u00e4nnande f\u00f6r specifik PharmaShell-struktur"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/7634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=7634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}